Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Parenti

Showing results (201-210 of 206) with videos related to

Pageof 21
Sort By:
You have reached the last page of results.This site can display upto 206 results.
The Journal of Infectious Diseases|November 7, 1998
A dose response study of hepatitis A vaccine in healthy adults who are > or = 30 years old and weigh > or = 77 kgJ S Bertino, S Thoelen, P VanDamme, et al.
AIDS (London, England)|January 6, 1999
A phase II/III trial of antimicrobial therapy with or without amikacin in the treatment of disseminated Mycobacterium avium infection in HIV-infected individuals. AIDS Clinical Trials Group Protocol 135 Study TeamD M Parenti, P L Williams, R Hafner, et al.
HIV Clinical Trials|August 14, 2003
Compact quadruple therapy with the lamivudine/zidovudine combination tablet plus abacavir and efavirenz, followed by the lamivudine/zidovudine/abacavir triple nucleoside tablet plus efavirenz in treatment-naïve HIV-infected adultsPeter J Ruane, David M Parenti, David M Margolis, et al.
The New England Journal of Medicine|August 8, 1996
Prophylaxis against disseminated Mycobacterium avium complex with weekly azithromycin, daily rifabutin, or both. California Collaborative Treatment GroupD V Havlir, M P Dubé, F R Sattler, et al.
Journal of Clinical Microbiology|November 10, 2017
Multicenter Evaluation of the Xpert MRSA NxG Assay for Detection of Methicillin-Resistant Staphylococcus aureus in Nasal SwabsMelanie L Yarbrough, David K Warren, Karen Allen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 30, 1998
Prophylaxis with weekly versus daily fluconazole for fungal infections in patients with AIDSD V Havlir, M P Dubé, J A McCutchan, et al.
Pageof 21

Showing results (201-210 of 206) with videos related to

Sort By:
Pageof 21
You have reached the last page of results.This site can display upto 206 results.
The Journal of Infectious Diseases|November 7, 1998
A dose response study of hepatitis A vaccine in healthy adults who are > or = 30 years old and weigh > or = 77 kgJ S Bertino, S Thoelen, P VanDamme, et al.
AIDS (London, England)|January 6, 1999
A phase II/III trial of antimicrobial therapy with or without amikacin in the treatment of disseminated Mycobacterium avium infection in HIV-infected individuals. AIDS Clinical Trials Group Protocol 135 Study TeamD M Parenti, P L Williams, R Hafner, et al.
HIV Clinical Trials|August 14, 2003
Compact quadruple therapy with the lamivudine/zidovudine combination tablet plus abacavir and efavirenz, followed by the lamivudine/zidovudine/abacavir triple nucleoside tablet plus efavirenz in treatment-naïve HIV-infected adultsPeter J Ruane, David M Parenti, David M Margolis, et al.
The New England Journal of Medicine|August 8, 1996
Prophylaxis against disseminated Mycobacterium avium complex with weekly azithromycin, daily rifabutin, or both. California Collaborative Treatment GroupD V Havlir, M P Dubé, F R Sattler, et al.
Journal of Clinical Microbiology|November 10, 2017
Multicenter Evaluation of the Xpert MRSA NxG Assay for Detection of Methicillin-Resistant Staphylococcus aureus in Nasal SwabsMelanie L Yarbrough, David K Warren, Karen Allen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 30, 1998
Prophylaxis with weekly versus daily fluconazole for fungal infections in patients with AIDSD V Havlir, M P Dubé, J A McCutchan, et al.
Pageof 21